207 related articles for article (PubMed ID: 21571403)
1. Selenocyanates and diselenides: a new class of potent antileishmanial agents.
Plano D; Baquedano Y; Moreno-Mateos D; Font M; Jiménez-Ruiz A; Palop JA; Sanmartín C
Eur J Med Chem; 2011 Aug; 46(8):3315-23. PubMed ID: 21571403
[TBL] [Abstract][Full Text] [Related]
2. Novel Heteroaryl Selenocyanates and Diselenides as Potent Antileishmanial Agents.
Baquedano Y; Alcolea V; Toro MÁ; Gutiérrez KJ; Nguewa P; Font M; Moreno E; Espuelas S; Jiménez-Ruiz A; Palop JA; Plano D; Sanmartín C
Antimicrob Agents Chemother; 2016 Jun; 60(6):3802-12. PubMed ID: 27067328
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of new adamantyl-substituted antileishmanial ether phospholipids.
Papanastasiou I; Prousis KC; Georgikopoulou K; Pavlidis T; Scoulica E; Kolocouris N; Calogeropoulou T
Bioorg Med Chem Lett; 2010 Sep; 20(18):5484-7. PubMed ID: 20719503
[TBL] [Abstract][Full Text] [Related]
4. Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates.
Garnica P; Etxebeste-Mitxeltorena M; Plano D; Moreno E; Espuelas S; Antonio Palop J; Jiménez-Ruiz A; Sanmartín C
Bioorg Med Chem Lett; 2020 Sep; 30(17):127371. PubMed ID: 32738977
[TBL] [Abstract][Full Text] [Related]
5. Antileishmanial activity of imidothiocarbamates and imidoselenocarbamates.
Moreno D; Plano D; Baquedano Y; Jiménez-Ruiz A; Palop JA; Sanmartín C
Parasitol Res; 2011 Jan; 108(1):233-9. PubMed ID: 20922428
[TBL] [Abstract][Full Text] [Related]
6. Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series.
Kieffer C; Cohen A; Verhaeghe P; Paloque L; Hutter S; Castera-Ducros C; Laget M; Rault S; Valentin A; Rathelot P; Azas N; Vanelle P
Bioorg Med Chem; 2015 May; 23(10):2377-86. PubMed ID: 25846065
[TBL] [Abstract][Full Text] [Related]
7. Molecular Dynamics Simulation and Docking Studies of Selenocyanate Derivatives as Anti-Leishmanial Agents.
Iman M; Kaboutaraki HB; Jafari R; Hosseini SA; Moghimi A; Khamesipour A; Harchegani AB; Davood A
Comb Chem High Throughput Screen; 2016; 19(10):847-854. PubMed ID: 27604957
[TBL] [Abstract][Full Text] [Related]
8. Novel hybrid selenosulfonamides as potent antileishmanial agents.
Baquedano Y; Moreno E; Espuelas S; Nguewa P; Font M; Gutierrez KJ; Jiménez-Ruiz A; Palop JA; Sanmartín C
Eur J Med Chem; 2014 Mar; 74():116-23. PubMed ID: 24448421
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
10. Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
Croft SL; Engel J
Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S4-8. PubMed ID: 16904717
[TBL] [Abstract][Full Text] [Related]
11. Peptidomimetic and organometallic derivatives of primaquine active against Leishmania infantum.
Vale-Costa S; Vale N; Matos J; Tomás A; Moreira R; Gomes P; Gomes MS
Antimicrob Agents Chemother; 2012 Nov; 56(11):5774-81. PubMed ID: 22926569
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of dicationic compounds against a North American foxhound isolate of Leishmania infantum.
Rosypal AC; Hall JE; Bakunova S; Patrick DA; Bakunov S; Stephens CE; Kumar A; Boykin DW; Tidwell RR
Vet Parasitol; 2007 Apr; 145(3-4):207-16. PubMed ID: 17298866
[TBL] [Abstract][Full Text] [Related]
13. Antileishmanial activity of semisynthetic lupane triterpenoids betulin and betulinic acid derivatives: synergistic effects with miltefosine.
Sousa MC; Varandas R; Santos RC; Santos-Rosa M; Alves V; Salvador JA
PLoS One; 2014; 9(3):e89939. PubMed ID: 24643019
[TBL] [Abstract][Full Text] [Related]
14. Effects of nitro-heterocyclic derivatives against Leishmania (Leishmania) infantum promastigotes and intracellular amastigotes.
Petri e Silva SC; Palace-Berl F; Tavares LC; Soares SR; Lindoso JA
Exp Parasitol; 2016 Apr; 163():68-75. PubMed ID: 26795261
[TBL] [Abstract][Full Text] [Related]
15. In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum.
Ordóñez-Gutiérrez L; Espada-Fernández R; Dea-Ayuela MA; Torrado JJ; Bolás-Fernandez F; Alunda JM
Int J Antimicrob Agents; 2007 Oct; 30(4):325-9. PubMed ID: 17631982
[TBL] [Abstract][Full Text] [Related]
16. Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis.
Santa-Rita RM; Henriques-Pons A; Barbosa HS; de Castro SL
J Antimicrob Chemother; 2004 Oct; 54(4):704-10. PubMed ID: 15329361
[TBL] [Abstract][Full Text] [Related]
17. Leishmanicidal activity of edelfosine, miltefosine and ilmofosine.
Azzouz S; Maache M; Garcia RG; Osuna A
Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):60-5. PubMed ID: 15667597
[TBL] [Abstract][Full Text] [Related]
18. Antileishmanial activity of antiretroviral drugs combined with miltefosine.
Costa S; Machado M; Cavadas C; do Céu Sousa M
Parasitol Res; 2016 Oct; 115(10):3881-7. PubMed ID: 27249967
[TBL] [Abstract][Full Text] [Related]
19. Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.
Lage PS; Chávez-Fumagalli MA; Mesquita JT; Mata LM; Fernandes SO; Cardoso VN; Soto M; Tavares CA; Leite JP; Tempone AG; Coelho EA
Parasitol Res; 2015 Dec; 114(12):4625-35. PubMed ID: 26346453
[TBL] [Abstract][Full Text] [Related]
20. Intracellular amastigote replication may not be required for successful in vitro selection of miltefosine resistance in Leishmania infantum.
Hendrickx S; Mondelaers A; Eberhardt E; Lachaud L; Delputte P; Cos P; Maes L
Parasitol Res; 2015 Jul; 114(7):2561-5. PubMed ID: 25877390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
